Ubiquitin ligases in cancer: Functions and clinical potentials.


Journal

Cell chemical biology
ISSN: 2451-9448
Titre abrégé: Cell Chem Biol
Pays: United States
ID NLM: 101676030

Informations de publication

Date de publication:
15 07 2021
Historique:
received: 26 01 2021
revised: 23 03 2021
accepted: 08 04 2021
pubmed: 12 5 2021
medline: 17 11 2021
entrez: 11 5 2021
Statut: ppublish

Résumé

Ubiquitylation, a highly regulated post-translational modification, controls many cellular pathways that are critical to cell homeostasis. Ubiquitin ligases recruit substrates and promote ubiquitin transfer onto targets, inducing proteasomal degradation or non-degradative signaling. Accumulating evidence highlights the critical role of dysregulated ubiquitin ligases in processes associated with the initiation and progression of cancer. Depending on the substrate specificity and biological context, a ubiquitin ligase can act either as a tumor promoter or as a tumor suppressor. In this review, we focus on the regulatory roles of ubiquitin ligases and how perturbations of their functions contribute to cancer pathogenesis. We also briefly discuss current strategies for targeting or exploiting ubiquitin ligases for cancer therapy.

Identifiants

pubmed: 33974914
pii: S2451-9456(21)00201-4
doi: 10.1016/j.chembiol.2021.04.008
pmc: PMC8286310
mid: NIHMS1693436
pii:
doi:

Substances chimiques

Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

918-933

Subventions

Organisme : NCI NIH HHS
ID : R01 CA076584
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM136250
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009161
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests M.P. is a consultant for and has financial interests in Coho Therapeutics, CullGen, Kymera Therapeutics, and SEED Therapeutics. M.P. is a cofounder of Coho Therapeutics, is on the SAB of CullGen and Kymera Therapeutics, and is a consultant for Santi Therapeutics. S.D. declares no competing interests.

Références

Hum Mol Genet. 2019 Mar 15;28(6):1007-1022
pubmed: 30481304
Nature. 2008 Mar 6;452(7183):98-102
pubmed: 18288109
Microbiol Mol Biol Rev. 2002 Jun;66(2):179-202
pubmed: 12040123
Trends Biochem Sci. 2012 Sep;37(9):364-72
pubmed: 22818162
Genes Dev. 2010 Aug 1;24(15):1580-9
pubmed: 20679392
Genes Dev. 2008 Apr 15;22(8):986-91
pubmed: 18367647
Nature. 1999 May 20;399(6733):271-5
pubmed: 10353251
Oncogene. 1998 Dec 10;17(23):2943-54
pubmed: 9881696
Proc Natl Acad Sci U S A. 2008 May 13;105(19):7100-5
pubmed: 18458331
Science. 2018 Dec 7;362(6419):1171-1177
pubmed: 30442766
Nat Med. 2017 Nov;23(11):1362-1368
pubmed: 28967920
Cell Metab. 2016 Jan 12;23(1):27-47
pubmed: 26771115
Nature. 2010 Nov 18;468(7322):400-5
pubmed: 20927106
J Biol Chem. 2005 Mar 4;280(9):7654-8
pubmed: 15611062
Cell. 2011 Sep 16;146(6):873-87
pubmed: 21925313
Science. 1996 Dec 6;274(5293):1652-9
pubmed: 8939846
Nature. 2014 Aug 7;512(7512):49-53
pubmed: 25043012
Mol Cell. 2009 Jan 16;33(1):109-16
pubmed: 19150432
Science. 1993 May 28;260(5112):1338-43
pubmed: 8493579
Curr Biol. 2000 Nov 2;10(21):1359-66
pubmed: 11084335
Cell. 2017 Feb 9;168(4):670-691
pubmed: 28187288
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5043-8
pubmed: 11309491
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
PLoS One. 2008 Jan 23;3(1):e1487
pubmed: 18213395
Lancet. 2003 Jun 14;361(9374):2059-67
pubmed: 12814730
Nat Rev Cancer. 2002 Apr;2(4):277-88
pubmed: 12001989
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21069-74
pubmed: 22106309
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):20857-8
pubmed: 22173637
Mol Cell Biol. 2004 Dec;24(24):10941-53
pubmed: 15572695
Nat Rev Mol Cell Biol. 2002 Feb;3(2):112-21
pubmed: 11836513
Nat Rev Cancer. 2009 Oct;9(10):749-58
pubmed: 19776744
Nat Cell Biol. 2018 May;20(5):586-596
pubmed: 29695787
Virus Res. 2002 Nov;89(2):213-28
pubmed: 12445661
Science. 2006 Oct 20;314(5798):467-71
pubmed: 17053147
Drug Resist Updat. 2015 Nov;23:1-11
pubmed: 26690337
Nat Rev Mol Cell Biol. 2004 Sep;5(9):739-51
pubmed: 15340381
Clin Cancer Res. 2005 Jun 15;11(12):4295-304
pubmed: 15958610
Nat Rev Cancer. 2006 May;6(5):369-81
pubmed: 16633365
Science. 2018 Dec 7;362(6419):1177-1182
pubmed: 30442762
Nat Rev Drug Discov. 2017 Feb;16(2):101-114
pubmed: 27885283
Nature. 2021 Apr;592(7856):789-793
pubmed: 33854235
Genes Dev. 2013 Oct 15;27(20):2179-91
pubmed: 24142871
Cancer Cell. 2002 Jun;1(5):459-68
pubmed: 12124175
Cell. 2019 Jul 11;178(2):316-329.e18
pubmed: 31257023
J Clin Oncol. 2018 Mar 20;36(9):867-874
pubmed: 29257710
Mol Cell. 2019 Jun 20;74(6):1264-1277.e7
pubmed: 31130363
Mol Cell. 2021 Mar 18;81(6):1292-1308.e11
pubmed: 33567269
Mol Cell. 2011 Oct 21;44(2):317-24
pubmed: 22017877
J Virol. 2004 Mar;78(6):2749-57
pubmed: 14990695
Cell. 2010 Jun 25;141(7):1117-34
pubmed: 20602996
J Natl Cancer Inst. 2005 Feb 2;97(3):166-7
pubmed: 15687356
Science. 2004 Feb 6;303(5659):844-8
pubmed: 14704432
J Med Chem. 1999 Sep 23;42(19):3789-99
pubmed: 10508428
J Exp Clin Cancer Res. 2011 Sep 26;30:87
pubmed: 21943236
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Cell. 2018 Dec 13;175(7):1958-1971.e15
pubmed: 30449619
Trends Cell Biol. 2014 Jan;24(1):26-34
pubmed: 24295852
Science. 2019 Mar 15;363(6432):1226-1230
pubmed: 30872527
Mol Cell. 2006 Aug 4;23(3):307-18
pubmed: 16885021
Nature. 2001 Sep 20;413(6853):316-22
pubmed: 11565034
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3371-6
pubmed: 24550499
Nature. 2015 Nov 19;527(7578):389-93
pubmed: 26503038
Cell. 2007 Nov 30;131(5):901-14
pubmed: 18001825
Nat Rev Cancer. 2014 Apr;14(4):233-47
pubmed: 24658274
Br J Cancer. 1995 May;71(5):981-5
pubmed: 7734324
Mol Cell. 2009 Oct 9;36(1):39-50
pubmed: 19818708
Cold Spring Harb Perspect Med. 2015 Apr 01;5(4):
pubmed: 25833940
Leukemia. 2020 May;34(5):1241-1252
pubmed: 31772299
Oncogene. 2006 Aug 7;25(34):4798-811
pubmed: 16892092
Biochim Biophys Acta. 2014 Jan;1843(1):150-62
pubmed: 23466868
Nat Chem Biol. 2017 Jun;13(6):675-680
pubmed: 28437394
Curr Drug Targets. 2010 Aug;11(8):1000-17
pubmed: 20426765
Trans Am Clin Climatol Assoc. 2017;128:298-307
pubmed: 28790514
PLoS Med. 2006 Oct;3(10):e420
pubmed: 17020408
Cell Death Differ. 2018 Jan;25(1):65-80
pubmed: 29149100
Science. 2017 Apr 28;356(6336):
pubmed: 28302793
Nat Rev Mol Cell Biol. 2020 Apr;21(4):246
pubmed: 32005970
Science. 2014 Jan 17;343(6168):301-5
pubmed: 24292625
Nat Genet. 2016 Jun;48(6):607-16
pubmed: 27158780
Semin Immunopathol. 2010 Jun;32(2):137-48
pubmed: 20458601
Nat Rev Clin Oncol. 2018 Sep;15(9):564-576
pubmed: 29955114
Nat Rev Mol Cell Biol. 2001 Apr;2(4):294-307
pubmed: 11283727
Nature. 2014 Feb 6;506(7486):52-7
pubmed: 24476824
Genes Chromosomes Cancer. 2002 May;34(1):9-16
pubmed: 11921277
Cell. 2009 May 1;137(3):413-31
pubmed: 19410540
Genes Dev. 2000 Oct 1;14(19):2393-409
pubmed: 11018009
J Hematol Oncol. 2017 Jul 3;10(1):133
pubmed: 28673313
Chem Biol. 2012 Dec 21;19(12):1515-24
pubmed: 23261596
Mol Cell. 2015 Sep 17;59(6):917-30
pubmed: 26344095
Nat Rev Cancer. 2018 Feb;18(2):69-88
pubmed: 29242641
Semin Cancer Biol. 2003 Feb;13(1):59-67
pubmed: 12507557
Trends Mol Med. 2019 May;25(5):428-443
pubmed: 30898473
Trends Cell Biol. 2020 Aug;30(8):640-652
pubmed: 32513610
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Cell Rep. 2017 Sep 19;20(12):2860-2875
pubmed: 28930682
Nat Chem Biol. 2020 Jan;16(1):7-14
pubmed: 31686031
Nat Rev Mol Cell Biol. 2016 Oct;17(10):626-42
pubmed: 27485899
Br J Haematol. 2014 Mar;164(6):811-21
pubmed: 24328678
Nat Rev Cancer. 2004 Apr;4(4):314-22
pubmed: 15057291
Cell. 2012 Sep 14;150(6):1182-95
pubmed: 22980979
Small GTPases. 2011 Jul;2(4):192-201
pubmed: 22145091
Oncogene. 2004 Mar 15;23(11):2028-36
pubmed: 15021890
Nature. 2020 Sep;585(7824):293-297
pubmed: 32494016
Immunology. 2007 May;121(1):1-14
pubmed: 17386080
Mol Cancer. 2007 Apr 02;6:24
pubmed: 17407548
Nat Rev Cancer. 2017 Jan 27;17(2):93-115
pubmed: 28127048
Nat Rev Drug Discov. 2006 Jul;5(7):596-613
pubmed: 16816840
Science. 2007 Dec 7;318(5856):1637-40
pubmed: 18006705
Nature. 2010 Jul 1;466(7302):138-42
pubmed: 20596027
Cell. 2012 Feb 3;148(3):399-408
pubmed: 22304911
Nature. 2016 Jun 22;535(7611):252-7
pubmed: 27338790
Nat Cell Biol. 2011 Oct 03;13(10):1161-9
pubmed: 21968989
Nat Chem Biol. 2019 Oct;15(10):937-944
pubmed: 31527835
EMBO Rep. 2013 Dec;14(12):1050-61
pubmed: 24232186
Nature. 2017 Jun 22;546(7659):554-558
pubmed: 28614300
Nat Cell Biol. 1999 Aug;1(4):193-9
pubmed: 10559916
EBioMedicine. 2020 Jan;51:102593
pubmed: 31901855
Cancer Res. 2010 Jun 15;70(12):4789-94
pubmed: 20501843
Trends Biochem Sci. 2010 Aug;35(8):427-33
pubmed: 20570523
Nat Genet. 2012 Dec;44(12):1310-5
pubmed: 23104009
Elife. 2020 Aug 17;9:
pubmed: 32804079
Nat Rev Cancer. 2011 Aug 24;11(9):629-43
pubmed: 21863050
Mol Cell. 2005 Oct 7;20(1):9-19
pubmed: 16209941
Cell Chem Biol. 2017 Sep 21;24(9):1181-1190
pubmed: 28648379
J Cell Sci. 2012 Feb 1;125(Pt 3):531-7
pubmed: 22389392
Cell. 2007 Nov 30;131(5):887-900
pubmed: 18001824
Mol Cell. 1999 Dec;4(6):1029-40
pubmed: 10635327
Curr Opin Hematol. 2008 Jul;15(4):381-90
pubmed: 18536578
Nature. 2004 Dec 9;432(7018):775-9
pubmed: 15592418
Nat Rev Cancer. 2008 Feb;8(2):83-93
pubmed: 18094723
Nature. 2012 Jan 5;481(7379):90-3
pubmed: 22113614
Oncogene. 2004 Mar 15;23(11):2057-70
pubmed: 15021893
Curr Opin Cell Biol. 2009 Dec;21(6):816-24
pubmed: 19775879
Nat Rev Drug Discov. 2019 Mar 6;:
pubmed: 30936511
Science. 2007 May 25;316(5828):1202-5
pubmed: 17525342
Nat Chem Biol. 2020 Nov;16(11):1199-1207
pubmed: 32747809
Mol Cell Biol. 2005 Jan;25(1):162-71
pubmed: 15601839
Biol Chem. 2006 Oct-Nov;387(10-11):1311-20
pubmed: 17081101
Mol Cell. 2016 Oct 6;64(1):12-23
pubmed: 27716480
Nat Cell Biol. 2013 May;15(5):472-80
pubmed: 23604317
Virology. 2009 Feb 20;384(2):335-44
pubmed: 19007963
Nat Med. 2002 Aug;8(8):793-800
pubmed: 12091876
APMIS. 2007 Feb;115(2):127-33
pubmed: 17295679
Cell. 2013 Aug 1;154(3):556-68
pubmed: 23911321
Mol Cell. 2006 Aug 4;23(3):319-29
pubmed: 16885022
Mol Cell. 2008 Jun 20;30(6):689-700
pubmed: 18570872
Nature. 2015 Jul 9;523(7559):183-188
pubmed: 26131937
Mol Cell. 2013 Mar 7;49(5):795-807
pubmed: 23416108
Genes Dev. 1999 Jan 1;13(1):76-86
pubmed: 9887101
Nat Rev Drug Discov. 2015 Aug;14(8):561-84
pubmed: 26228759
Cancer Cell. 2003 Jun;3(6):519-23
pubmed: 12842080
Int J Cancer. 2007 Jun 1;120(11):2344-52
pubmed: 17311258
Dev Cell. 2003 Jun;4(6):799-812
pubmed: 12791266
Endocrinology. 2013 Nov;154(11):4030-45
pubmed: 24035998
Nature. 2021 Apr;592(7856):794-798
pubmed: 33854239
Cell. 2017 Apr 20;169(3):381-405
pubmed: 28431241
Nat Genet. 2018 May;50(5):645-651
pubmed: 29610475
Trends Cell Biol. 2010 May;20(5):299-309
pubmed: 20172729
Nat Med. 2014 Dec;20(12):1401-9
pubmed: 25419709
Nat Rev Mol Cell Biol. 2003 Jul;4(7):552-65
pubmed: 12838338
Cancer Metastasis Rev. 2003 Dec;22(4):337-58
pubmed: 12884910
Cell. 2009 May 29;137(5):873-86
pubmed: 19446321
Nat Rev Cancer. 2013 Feb;13(2):83-96
pubmed: 23303139
J Virol. 2007 Sep;81(18):9737-47
pubmed: 17609271
Carcinogenesis. 2007 Jul;28(7):1408-17
pubmed: 17372273
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4419-24
pubmed: 15070733
Ann Rheum Dis. 2018 Oct;77(10):1516-1523
pubmed: 29945920
Viruses. 2019 Oct 09;11(10):
pubmed: 31600915
N Engl J Med. 2017 Jan 26;376(4):354-366
pubmed: 28121507
Nat Cell Biol. 2012 Mar 04;14(4):375-85
pubmed: 22388891
Mol Cell Biol. 2003 Jan;23(1):26-37
pubmed: 12482958
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20759-63
pubmed: 18077395
Nat Chem Biol. 2020 Jan;16(1):15-23
pubmed: 31819272
J Biol Chem. 2006 Aug 25;281(34):24756-68
pubmed: 16790436
Genes Dev. 2001 Dec 1;15(23):3104-17
pubmed: 11731475
Mol Cell. 2011 Oct 21;44(2):290-303
pubmed: 22017875
Am J Cancer Res. 2020 Mar 01;10(3):704-726
pubmed: 32266086
Eur J Cancer. 1994;30A(7):982-4
pubmed: 7946596
Mol Cell. 2015 Sep 17;59(6):904-16
pubmed: 26344096
Nat Rev Mol Cell Biol. 2013 Jun;14(6):369-81
pubmed: 23657496
EMBO J. 2019 Oct 15;38(20):e101443
pubmed: 31424118
Nature. 2007 Apr 5;446(7136):640-5
pubmed: 17410169
Nature. 2018 Dec;564(7734):130-135
pubmed: 30487606
Annu Rev Genomics Hum Genet. 2013;14:355-69
pubmed: 23875798
Pharmacol Ther. 1998 Jun;78(3):129-39
pubmed: 9690814
J Natl Cancer Inst. 2004 Aug 4;96(15):1161-70
pubmed: 15292388
Clin Microbiol Rev. 2003 Jan;16(1):1-17
pubmed: 12525422
Nat Rev Cancer. 2008 Jun;8(6):438-49
pubmed: 18500245
Science. 2014 Jan 17;343(6168):305-9
pubmed: 24292623
Nat Rev Mol Cell Biol. 2020 Oct;21(10):607-632
pubmed: 32576977
J Mol Med (Berl). 2016 Dec;94(12):1313-1326
pubmed: 27695879
Nat Cell Biol. 2020 Sep;22(9):1130-1142
pubmed: 32839549
Cold Spring Harb Perspect Med. 2017 May 1;7(5):
pubmed: 28270530
Nat Rev Cancer. 2020 Feb;20(2):74-88
pubmed: 31686003
Trends Cell Biol. 2013 Mar;23(3):135-40
pubmed: 23182110
Cell Death Differ. 2020 Mar;27(3):1023-1035
pubmed: 31337872
Nat Rev Mol Cell Biol. 2005 Jan;6(1):9-20
pubmed: 15688063
Nat Rev Cancer. 2011 Jul 07;11(8):558-72
pubmed: 21734724
Structure. 2019 Nov 5;27(11):1625-1633.e3
pubmed: 31693911
Nat Med. 2017 Sep;23(9):1046-1054
pubmed: 28805821
Nat Rev Drug Discov. 2014 Dec;13(12):889-903
pubmed: 25394868
Science. 2010 Mar 12;327(5971):1345-50
pubmed: 20223979
N Engl J Med. 2016 Nov 3;375(18):1767-1778
pubmed: 27806234
Mol Cell. 2011 Oct 21;44(2):304-16
pubmed: 22017876
Genes Cancer. 2011 Dec;2(12):1117-33
pubmed: 22866203
Cell. 2012 May 25;149(5):1023-34
pubmed: 22632967
Mol Cell Biol. 2012 Feb;32(3):590-605
pubmed: 22124152
Int J Oncol. 2001 May;18(5):959-64
pubmed: 11295041
Cell. 2006 Nov 17;127(4):679-95
pubmed: 17110329
Nat Rev Cancer. 2002 Sep;2(9):673-82
pubmed: 12209156
Nature. 2020 Dec;588(7836):164-168
pubmed: 33208943
Annu Rev Biochem. 1998;67:425-79
pubmed: 9759494
Oncogene. 1997 Feb 6;14(5):595-602
pubmed: 9053858
Cold Spring Harb Perspect Biol. 2013 Mar 01;5(3):a008904
pubmed: 23457258
Nature. 2018 Jan 4;553(7686):91-95
pubmed: 29160310
Nat Genet. 2012 May 20;44(6):685-9
pubmed: 22610119
Nature. 2003 Nov 6;426(6962):87-91
pubmed: 14603323

Auteurs

Shanshan Duan (S)

Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA.

Michele Pagano (M)

Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, NY, USA; Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA; Howard Hughes Medical Institute, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: michele.pagano@nyumc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH